Technologies collectively called omics enable simultaneous measurement of an enormous number of biomolecules; for example, genomics investigates thousands of DNA sequences, and proteomics examines large numbers of proteins. Scientists are using these technologies to develop innovative tests to detect disease and to predict a patient's likelihood of responding to specific drugs. Following a recent case involving premature use of omics-based tests in cancer clinical trials at Duke University, the NCI requested that the IOM establish a committee to recommend ways to strengthen omics-based test development and evaluation. This report identifies best practices to enhance development, evaluation, and translation of omics-based tests while simultaneously reinforcing steps to ensure that these tests are appropriately assessed for scientific validity before they are used to guide patient treatment in clinical trials.
Table of ContentsLe informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Da: HPB-Red, Dallas, TX, U.S.A.
Paperback. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Codice articolo S_396546357
Quantità: 1 disponibili
Da: Swan Trading Company, GEORGETOWN, TX, U.S.A.
paperback. Condizione: Good. Softcover ex-library with typical marks shows moderate cover wear. Text is unmarked. Ships FAST! Codice articolo 2601010002
Quantità: 1 disponibili